Purified Anti-Human CD40 Antibody[G28.5]

Purified Anti-Human CD40 Antibody[G28.5]

Introducing the Purified Anti-Human CD40 Antibody [G28.5], a highly effective and reliable solution for targeted immunotherapy. This antibody has been specifically designed to target the CD40 antigen, a protein that is expressed on the surface of various immune cells, including B cells, dendritic cells, and macrophages.

The Purified Anti-Human CD40 Antibody [G28.5] has undergone rigorous purification processes to ensure its purity and potency. It has been extensively tested and validated for its ability to bind to the CD40 antigen with high specificity and affinity, making it an ideal tool for research and clinical applications.

This antibody has been shown to effectively activate immune cells and enhance their ability to recognize and eliminate cancer cells, making it a promising candidate for cancer immunotherapy. It has also been demonstrated to have potential therapeutic applications in autoimmune diseases, such as rheumatoid arthritis and lupus.

The Purified Anti-Human CD40 Antibody [G28.5] is available in various formats, including purified, biotinylated, and conjugated to fluorescent dyes, to suit a wide range of experimental needs. It is supplied in a convenient and easy-to-use format, making it an ideal choice for researchers and clinicians alike.

In summary, the Purified Anti-Human CD40 Antibody [G28.5] is a highly purified and potent antibody that has been extensively validated for its specificity and affinity to the CD40 antigen. Its potential applications in cancer immunotherapy and autoimmune diseases make it a valuable tool for researchers and clinicians seeking to advance their understanding and treatment of these conditions.